RPID
NASDAQ
$2.07
Rapid Micro Biosystems Inc - Class A (RPID)
Rapid Micro Biosystems Inc (RPID) is an innovative biotechnology firm at the forefront of revolutionizing microbiological quality control for the pharmaceutical and biotechnology industries. Utilizing advanced automated microbial detection technologies, RPID significantly improves the accuracy and efficiency of microbial testing, addressing the stringent regulatory requirements within these sectors. As the demand for rapid quality assurance solutions continues to grow, Rapid Micro is well-positioned to spearhead advancements in testing methodologies, ensuring product safety and integrity in highly regulated environments.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $6.67 (+222.22%)
Market Cap
$100M
Free Cash Flow Yield
-37.83%
Beta (5Y)
1.46
Price Chart
Valuation
Market Cap$100M
P/S3.00
P/B5.07
Profitability
Total Revenue (TTM)$34M
Gross Profit (TTM)$1.01M
EBITDA-$46M
Profit Margin-145.8%
Operating Margin-173.1%
EPS-$1.09
Financial Health
Debt-to-Equity93.4%
Free Cash Flow Yield-37.83%
Growth & Risk
Revenue 5Y CAGR+10.29%
Beta (5Y)1.46
Sharpe Ratio-0.19